• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Balchem Corporation

    2/4/22 8:57:52 AM ET
    $BCPC
    Major Chemicals
    Industrials
    Get the next $BCPC alert in real time by email
    SC 13G 1 d310060dsc13g.htm SC 13G SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. ___)

     

     

    Balchem Corporation

    (Name of Issuer)

    Common Stock, $0.06 2/3 par value

    (Title of Class of Securities)

    057665200

    (CUSIP Number)

    December 31, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 057665200

     

     

      1    

      NAME OF REPORTING PERSON

      I.R.S. IDENTIFICATION NO. OF REPORTING PERSON (VOLUNTARY) (ENTITIES ONLY):

     

      APG Asset Management US Inc.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☒

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware, United States of America

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      2,715,000

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      2,715,000

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

       2,715,000

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

       8.4%*

    12  

      TYPE OF REPORTING PERSON

     

      CO, IA

     

    *

    Based on 32,381,611 shares of Common Stock outstanding as of October 21, 2021, as reported in the Issuer’s Report on Form 10-Q for the period ended September 30, 2021 filed with the Securities and Exchange Commission on October 29, 2021.

     

    2


    CUSIP No. 057665200

     

     

      1    

      NAME OF REPORTING PERSON

      I.R.S. IDENTIFICATION NO. OF REPORTING PERSON (VOLUNTARY) (ENTITIES ONLY):

     

      APG Asset Management, N.V.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Kingdom of the Netherlands

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      2,715,000

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      2,715,000

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      2,715,000

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      8.4%*

    12  

      TYPE OF REPORTING PERSON

     

      CO

     

    *

    Based on 32,381,611 shares of Common Stock outstanding as of October 21, 2021, as reported in the Issuer’s Report on Form 10-Q for the period ended September 30, 2021 filed with the Securities and Exchange Commission on October 29, 2021.

     

    3


    CUSIP No. 057665200

     

      1    

      NAME OF REPORTING PERSON

      I.R.S. IDENTIFICATION NO. OF REPORTING PERSON (VOLUNTARY) (ENTITIES ONLY):

     

      APG Groep, N.V.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Kingdom of the Netherlands

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      2,715,000

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      2,715,000

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      2,715,000

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      8.4%*

    12  

      TYPE OF REPORTING PERSON

     

      CO

     

    *

    Based on 32,381,611 shares of Common Stock outstanding as of October 21, 2021, as reported in the Issuer’s Report on Form 10-Q for the period ended September 30, 2021 filed with the Securities and Exchange Commission on October 29, 2021.

     

    4


    CUSIP No. 057665200

     

      1    

      NAME OF REPORTING PERSON

      I.R.S. IDENTIFICATION NO. OF REPORTING PERSON (VOLUNTARY) (ENTITIES ONLY):

     

      Stichting Pensioenfonds ABP

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☒

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Kingdom of the Netherlands

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      2,715,000

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      2,715,000

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      2,715,000

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      8.4%*

    12  

      TYPE OF REPORTING PERSON

     

      EP

     

    *

    Based on 32,381,611 shares of Common Stock outstanding as of October 21, 2021, as reported in the Issuer’s Report on Form 10-Q for the period ended September 30, 2021 filed with the Securities and Exchange Commission on October 29, 2021.

     

    5


    CUSIP No. 057665200

     

    SCHEDULE 13G

     

    ITEM 1(a) -   

    NAME OF ISSUER:

     

    Balchem Corporation

    ITEM 1(b) -   

    ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

     

    52 Sunrise Park Road, New Hampton, NY 10958

    ITEM 2(a) -   

    NAME OF PERSON FILING:

     

    (1) APG Asset Management US Inc.

    (2) APG Asset Management, N.V.

    (3) APG Groep, N.V.

    (4) Stichting Pensioenfonds ABP

       The Joint Filing Agreement among the Reporting Persons is attached hereto as Exhibit 1.
    ITEM 2(b) -    ADDRESS OF PRINCIPAL BUSINESS OFFICE:
      

    (1) 666 3rd Ave., 2nd Floor, New York, NY 10017

    (2) Gustav Mahlerplein 3, 1082 MS Amsterdam

    (3) Oude Lindestraat 70, Postbus 6401, Heerlen, Netherlands

    (4) PO Box 4806, 6401 JL Heerlen, Netherlands

    ITEM 2(c) -   

    CITIZENSHIP:

     

    (1) Delaware, United States of America (a Delaware corporation)

    (2) Kingdom of the Netherlands (a Dutch corporation)

    (3) Kingdom of the Netherlands (a Dutch corporation)

    (4) Kingdom of the Netherlands (a Dutch pension plan)

    ITEM 2(d) -   

    TITLE OF CLASS OF SECURITIES:

     

    Common Stock, $0.06 2/3 par value

    ITEM 2(e) -   

    CUSIP NUMBER:

     

    057665200

     

    6


    CUSIP No. 057665200

     

    ITEM 3.   IF THIS STATEMENT IS FILED PURSUANT TO §§ 240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

    (a)   

    ☐

       Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
    (b)   

    ☐

       Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 73c).
    (c)   

    ☐

       Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C.78c).
    (d)   

    ☐

       Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e)    ☒    An investment adviser in accordance with §13d-1(b)(1)(ii)(E).
          (with respect to APG Asset Management US, Inc.)
    (f)    ☒    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
          (with respect to Stichting Pensioenfonds ABP)
    (g)   

    ☐

       A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
    (h)   

    ☐

       A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
    (i)   

    ☐

       A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
    (j)   

    ☐

       A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J).
    (k)   

    ☐

       Group, in accordance with §240.13d-1(b)(1)(ii)(K).

    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J) , please specify the type of institution: ____    

     

    ITEM 4 -

    OWNERSHIP:

    The information requested in this item is incorporated herein by reference to the cover pages to this Schedule 13G.

    APG Asset Management, N.V. (“APG NL”) is wholly-owned by APG Groep, N.V. (“APG Groep”) and is the investment manager with respect to the securities to which this statement relates. Pursuant to an Investment Management Agreement, APG NL has delegated its investment and voting power with respect to such securities to APG Asset Management US, Inc. (“APG US”), which is its wholly-owned subsidiary. Stichting Pensioenfonds ABP is the majority owner of APG Groep. By virtue of the relationships described above, each of the Reporting Persons may be deemed to share beneficial ownership of the securities to which this statement relates and may be deemed to be a member of a “group” (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended). However, each Reporting Person disclaims membership in any such group, and further, each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.

     

    7


    CUSIP No. 057665200

     

    ITEM 5 -

    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

    Not applicable.

     

    ITEM 6 -

    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

    Not applicable.

     

    ITEM 7 -

    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY:

    Not applicable.

     

    ITEM 8 -

    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

    Not applicable.

     

    ITEM 9 -

    NOTICE OF DISSOLUTION OF GROUP:

    Not applicable.

     

    ITEM 10 -

    CERTIFICATION:

    By signing below the undersigned certify that, to the best of the undersigned’s knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

    8


    CUSIP No. 057665200

     

    SIGNATURE

    After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

    Date: February 4, 2022

     

    APG ASSET MANAGEMENT US, INC.
    By:  

    /s/ Evan Gordon

    Name: Evan Gordon
    Title: Chief Compliance Officer
    APG ASSET MANAGEMENT, N.V.
    By:  

    /s/ Evan Gordon

    Name: Evan Gordon
    Title: Chief Compliance Officer
    APG GROEP, N.V.
    By:  

    /s/ Evan Gordon

    Name: Evan Gordon
    Title: Chief Compliance Officer
    STICHTING PENSIOENFONDS ABP
    By:  

    /s/ Evan Gordon

    Name: Evan Gordon
    Title: Chief Compliance Officer

     

    9

    Get the next $BCPC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BCPC

    DatePrice TargetRatingAnalyst
    3/8/2022$170.00 → $155.00Buy
    HC Wainwright & Co.
    2/22/2022$175.00Neutral → Buy
    Sidoti
    1/10/2022$160.00 → $170.00Buy
    HC Wainwright & Co.
    11/29/2021$175.00Buy → Neutral
    Sidoti
    8/2/2021$140.00 → $145.00Overweight → Equal-Weight
    Stephens & Co.
    8/2/2021$145.00 → $160.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $BCPC
    SEC Filings

    See more
    • SEC Form 11-K filed by Balchem Corporation

      11-K - BALCHEM CORP (0000009326) (Filer)

      6/24/25 4:38:30 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - BALCHEM CORP (0000009326) (Filer)

      6/20/25 4:16:23 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Balchem Corporation

      SCHEDULE 13G/A - BALCHEM CORP (0000009326) (Subject)

      5/14/25 4:34:20 PM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $BCPC
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $BCPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • HC Wainwright & Co. reiterated coverage on Balchem with a new price target

      HC Wainwright & Co. reiterated coverage of Balchem with a rating of Buy and set a new price target of $155.00 from $170.00 previously

      3/8/22 6:19:56 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem upgraded by Sidoti with a new price target

      Sidoti upgraded Balchem from Neutral to Buy and set a new price target of $175.00

      2/22/22 8:56:13 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • HC Wainwright & Co. reiterated coverage on Balchem with a new price target

      HC Wainwright & Co. reiterated coverage of Balchem with a rating of Buy and set a new price target of $170.00 from $160.00 previously

      1/10/22 6:15:56 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2025 Financial Results on July 31, 2025

      MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Second quarter results will be published prior to the market opening on Thursday, July 31, 2025. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. To improve the quality of both the live and recorded audio for our conference calls, we have ch

      7/17/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation to Present at the CJS Annual New Ideas Summer Conference on July 10, 2025

      MONTVALE, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the CJS Annual New Ideas Summer Conference on July 10, 2025. Ted Harris, Chairman of the Board, Chief Executive Officer, and President, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest qual

      6/26/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025

      MONTVALE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials and Materials Conference on June 11, 2025. Ted Harris, Chairman of the Board, Chief Executive Officer, and President, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the fi

      5/28/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Amendment: SVP and GM, Specialty Products Van Gunsteren Job Leonard was granted 2,128 shares and covered exercise/tax liability with 964 shares, increasing direct ownership by 14% to 9,446 units (SEC Form 4)

      4/A - BALCHEM CORP (0000009326) (Issuer)

      4/11/25 7:11:10 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Amendment: SVP & Chief HR Officer Tignor Michael Brent was granted 3,497 shares and covered exercise/tax liability with 1,156 shares, increasing direct ownership by 35% to 9,123 units (SEC Form 4)

      4/A - BALCHEM CORP (0000009326) (Issuer)

      4/11/25 6:43:35 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • Amendment: SVP Chief Supply Chain Officer Reid Martin Luther was granted 3,889 shares and covered exercise/tax liability with 1,059 shares, increasing direct ownership by 49% to 8,591 units (SEC Form 4)

      4/A - BALCHEM CORP (0000009326) (Issuer)

      4/11/25 6:38:36 PM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Leadership Updates

    Live Leadership Updates

    See more
    • AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

      BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. ("AzurRx" or the "Company") (NASDAQ:AZRX), a company specializing in the development of targeted non-systemic, therapies for gastrointestinal (GI) diseases, today announced the appointment of Terry Coelho to its Board of Directors effective immediately. The appointment increases the size of AzurRx's Board to seven members. Ms. Coelho currently serves as the Executive Vice President and Chief Financial Officer at BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a commercial-stage specialty pharmaceutical company. During her more than 30-year career, Ms. Coelho has held numerous senior level financial an

      8/16/21 8:00:00 AM ET
      $AZRX
      $BCPC
      $BDSI
      Major Pharmaceuticals
      Health Care
      Major Chemicals
      Industrials

    $BCPC
    Financials

    Live finance-specific insights

    See more
    • Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2025 Financial Results on July 31, 2025

      MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Second quarter results will be published prior to the market opening on Thursday, July 31, 2025. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. To improve the quality of both the live and recorded audio for our conference calls, we have ch

      7/17/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation Reports First Quarter 2025 Financial Results

      MONTVALE, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) reported today financial results for its 2025 fiscal first quarter ended March 31, 2025. For the quarter, the Company reported net sales of $250.5 million, net earnings of $37.1 million, adjusted EBITDA(a) of $66.3 million, and free cash flow(a) of $31.0 million. Ted Harris, Chairman, President and CEO of Balchem said, "The first quarter was an excellent start to the year for Balchem, with sales and earnings growth in all three segments. We delivered record net sales and adjusted EBITDA, strong net earnings, and solid first quarter cash flows." First Quarter 2025 Financial Highlights: Record net sales o

      4/24/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials
    • Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April 24, 2025

      MONTVALE, N.J., April 11, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Thursday, April 24, 2025, at 11:00 AM Eastern Time (ET) to review first quarter 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. First quarter results will be published prior to the market opening on Thursday, April 24, 2025. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341),

      4/11/25 7:00:00 AM ET
      $BCPC
      Major Chemicals
      Industrials

    $BCPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Balchem Corporation

      SC 13G/A - BALCHEM CORP (0000009326) (Subject)

      11/13/24 6:56:07 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Balchem Corporation (Amendment)

      SC 13G/A - BALCHEM CORP (0000009326) (Subject)

      2/13/24 4:59:02 PM ET
      $BCPC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Balchem Corporation (Amendment)

      SC 13G/A - BALCHEM CORP (0000009326) (Subject)

      2/9/24 11:29:17 AM ET
      $BCPC
      Major Chemicals
      Industrials